A new strategy to block the progression of castration‑resistant prostate cancer

Aim of the project
This project aims to develop new drugs that block the androgen receptor—a key protein in tumor growth—through a mechanism different from the one currently used, offering an alternative for treating advanced prostate cancer when existing therapies stop being effective.

  • Dra. Alba Jiménez
  • Research centre: Instituto de Investigación Biomédica de Bellvitge (IDIBELL)
  • Year: 2025
  • Profile in Spanish: Link